14 research outputs found
Challenges and applications of proteomics for analysis of changes in early postmortem meat
Lung- and diaphragm-protective ventilation by titrating inspiratory support to diaphragm effort: a randomized clinical trial
OBJECTIVES:
Lung- and diaphragm-protective ventilation is a novel concept that aims to limit the detrimental effects of mechanical ventilation on the diaphragm while remaining within limits of lung-protective ventilation. The premise is that low breathing effort under mechanical ventilation causes diaphragm atrophy, whereas excessive breathing effort induces diaphragm and lung injury. In a proof-of-concept study, we aimed to assess whether titration of inspiratory support based on diaphragm effort increases the time that patients have effort in a predefined âdiaphragm-protectiveâ range, without compromising lung-protective ventilation.
DESIGN:
Randomized clinical trial.
SETTING:
Mixed medical-surgical ICU in a tertiary academic hospital in the Netherlands.
PATIENTS:
Patients (n = 40) with respiratory failure ventilated in a partially-supported mode.
INTERVENTIONS:
In the intervention group, inspiratory support was titrated hourly to obtain transdiaphragmatic pressure swings in the predefined âdiaphragm-protectiveâ range (3â12âcm H2O). The control group received standard-of-care.
MEASUREMENTS AND MAIN RESULTS:
Transdiaphragmatic pressure, transpulmonary pressure, and tidal volume were monitored continuously for 24 hours in both groups. In the intervention group, more breaths were within âdiaphragm-protectiveâ range compared with the control group (median 81%; interquartile range [64â86%] vs 35% [16â60%], respectively; p < 0.001). Dynamic transpulmonary pressures (20.5 ± 7.1 vs 18.5 ± 7.0âcm H2O; p = 0.321) and tidal volumes (7.56 ± 1.47 vs 7.54 ± 1.22âmL/kg; p = 0.961) were not different in the intervention and control group, respectively.
CONCLUSIONS:
Titration of inspiratory support based on patient breathing effort greatly increased the time that patients had diaphragm effort in the predefined âdiaphragm-protectiveâ range without compromising tidal volumes and transpulmonary pressures. This study provides a strong rationale for further studies powered on patient-centered outcomes
Effect of levosimendan on the contractility of muscle fibers from nemaline myopathy patients with mutations in the nebulin gene
Diaphragm adaptations in patients with COPD.
Contains fulltext :
70068.pdf ( ) (Open Access)Inspiratory muscle weakness in patients with COPD is of major clinical relevance. For instance, maximum inspiratory pressure generation is an independent determinant of survival in severe COPD. Traditionally, inspiratory muscle weakness has been ascribed to hyperinflation-induced diaphragm shortening. However, more recently, invasive evaluation of diaphragm contractile function, structure, and biochemistry demonstrated that cellular and molecular alterations occur, of which several can be considered pathologic of nature. Whereas the fiber type shift towards oxidative type I fibers in COPD diaphragm is regarded beneficial, rendering the overloaded diaphragm more resistant to fatigue, the reduction of diaphragm fiber force generation in vitro likely contributes to diaphragm weakness. The reduced diaphragm force generation at single fiber level is associated with loss of myosin content in these fibers. Moreover, the diaphragm in COPD is exposed to oxidative stress and sarcomeric injury. This review postulates that the oxidative stress and sarcomeric injury activate proteolytic machinery, leading to contractile protein wasting and, consequently, loss of force generating capacity of diaphragm fibers in patients with COPD. Interestingly, several of these presumed pathologic alterations are already present early in the course of the disease (GOLD I/II), although these patients appear not limited in their daily life activities. Treatment of diaphragm dysfunction in COPD is complex since its etiology is unclear, but recent findings indicate the ubiquitin-proteasome pathway as a prime target to attenuate diaphragm wasting in COPD
Novel deletions in TPM3 define a hypercontractile phenotype with marked congenital muscle stiffness: Expanding the spectrum of TPM3 related disease
Estimulação elétrica transcutùnea diafragmåtica pela corrente russa em portadores de DPOC
Muscle histopathology in nebulin-related nemaline myopathy: ultrastrastructural findings correlated to disease severity and genotype
Lung- and Diaphragm-Protective Ventilation
Mechanical ventilation can cause acute diaphragm atrophy and injury, and this is associated with poor clinical outcomes. Although the importance and impact of lung-protective ventilation is widely appreciated and well established, the concept of diaphragm-protective ventilation has recently emerged as a potential complementary therapeutic strategy. This Perspective, developed from discussions at a meeting of international experts convened by PLUG (the Pleural Pressure Working Group) of the European Society of Intensive Care Medicine, outlines a conceptual framework for an integrated lung- and diaphragm-protective approach to mechanical ventilation on the basis of growing evidence about mechanisms of injury. We propose targets for diaphragm protection based on respiratory effort and patient-ventilator synchrony. The potential for conflict between diaphragm protection and lung protection under certain conditions is discussed; we emphasize that when conflicts arise, lung protection must be prioritized over diaphragm protection. Monitoring respiratory effort is essential to concomitantly protect both the diaphragm and the lung during mechanical ventilation. To implement lung- and diaphragm-protective ventilation, new approaches to monitoring, to setting the ventilator, and to titrating sedation will be required. Adjunctive interventions, including extracorporeal life support techniques, phrenic nerve stimulation, and clinical decision-support systems, may also play an important role in selected patients in the future. Evaluating the clinical impact of this new paradigm will be challenging, owing to the complexity of the intervention. The concept of lung- and diaphragm-protective ventilation presents a new opportunity to potentially improve clinical outcomes for critically ill patients
A childhood-onset nemaline myopathy caused by novel heterozygote variants in the nebulin gene with literature review
TPM3 deletions cause a hypercontractile congenital muscle stiffness phenotype
Running head: Deletions)in)TPM3)cause)a)hypercontractile)phenotype Number of words in abstract: 242 Number of words in main text: 4946 Number of figures: 6 Number of tables: 1 ABSTRACT Objective: Mutations in TPM3, encoding Tpm3.12, cause a clinically and histopathologically diverse group of myopathies characterized by muscle weakness. We report two patients with novel de novo Tpm3.12 single glutamic acid deletions at positions ÎE218 and ÎE224, resulting in a significant hypercontractile phenotype with congenital muscle stiffness, rather than weakness, and respiratory failure in one case. Methods: The effect of the Tpm3.12 deletions on the contractile properties in dissected patient myofibers was measured. We used quantitative in vitro motility assay (IVMA) to measure Ca 2+ -sensitivity of thin filaments reconstituted with recombinant Tpm3.12 âE218 and âE224. Results: Contractility studies on permeabilized myofibers demonstrated reduced maximal active tension from both patients with increased Ca 2+ sensitivity with altered cross-bridge cycling kinetics in ÎE224 fibers. In vitro motility studies showed a two-fold increase in Ca 2+ -sensitivity of the fraction of filaments motile and the filament sliding velocity concentrations for both mutations. Interpretation: This data indicates that Tpm3.12 deletions ÎE218 and ÎE224 result in increased Ca 2+ sensitivity of the troponin-tropomyosin complex, resulting in abnormally active interaction of actin and myosin complex. Both mutations are located in the charged motifs of the actin-binding residues of tropomyosin 3, thus disrupting the electrostatic interactions that facilitate accurate tropomyosin binding with actin necessary to prevent the on-state. The mutations destabilize the off-state and result in excessively sensitized excitation-contraction coupling of the contractile apparatus. This work expands the phenotypic spectrum of TPM3-related disease and provides insights into the pathophysiological mechanisms of the actin-tropomyosin complex